Announcement
Isomorphic Labs says it raised $5 billion for AI drug design
The company says Greenoaks and Sequoia Capital co-led its $5 billion Series C funding round.
TLDR
Isomorphic Labs says it raised a $5 billion Series C co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and continued significant investment from Alphabet. The company says it is scaling IsoDDE, its AI drug-design engine, and its pipeline of potential medicines.
Combined views
32.3K
12 Sources, first seen ago

Comments